Mesenchymal stromal cells (MSCs) harbor great therapeutic potential for numerous
diseases. From early clinical trials, success and failure analysis, bench-to-bedside and back-to-…

Detrimental actions of donor-specific antibodies (DSAs) directed against both major
histocompatibility antigens (human leukocyte antigen [HLA]) and specific non-HLA antigens …

During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …

Background Systemic sclerosis (SSc) features autoimmunity, vasculopathy and tissue fibrosis.
The renin-angiotensin and endothelin systems have been implicated in vasculopathy and …

In this study, we investigated effects of a novel NAD(P)H oxidase (Nox)-inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine
(VAS2870) on oxidized low-density …

While therapeutic mesenchymal stromal/stem cells (MSCs) have usually been obtained from
bone marrow, perinatal tissues have emerged as promising new sources of cells for stromal …

G protein-coupled receptors (GPCR) are involved in various physiological and pathophysiological
processes. Functional autoantibodies targeting GPCRs have been associated with …

Confirmed clinical relevance of non-HLA humoral responses in solid organ transplantation
emphasizes the need for revision of classical diagnostic approaches based solely on …

Heterogeneous populations of human bone marrow-derived stromal cells (BMSC) are
among the most frequently tested cellular therapeutics for treating degenerative and immune …

Vascular endothelial growth factor (VEGF) is implicated in the peritoneal membrane
remodeling that limits ultrafiltration in patients on peritoneal dialysis (PD). Although the exact …